Global Oncolytic Adenovirus Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

How Big Is the Oncolytic Adenovirus Market Size Expected to Be by 2034?
The market size for the oncolytic adenovirus has seen a dramatic increase in recent times. Projected to rise from $122.31 billion in 2024 to a substantial $132.87 billion in 2025, it boasts a compound annual growth rate (CAGR) of 8.6%. The impressive growth during the historical period is credited to the surge in cancer cases, an escalating demand for specific cancer treatments, increased funding for research and development, enhancements in delivery techniques, and regulatory endorsements.

In the coming years, the market size for oncolytic adenovirus is predicted to witness significant growth and reach $183.22 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.4%. Factors that will contribute to this growth include the increasing prevalence and incidence of cancer, the use of combination therapies, technological progress in virus engineering, regulatory improvements and approvals, and a surge in oncology research funding. Key trends during the forecast period will be the refinement of viral engineering methods, advances in drug delivery systems, progress in tumor targeting precision, improvements in immunotherapy combinations, and developments in patient monitoring and diagnostics.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21235

What Are the Emerging Segments Within the Oncolytic Adenovirus Market?
The oncolytic adenovirus market covered in this report is segmented -

1) By Virus Type: Adenovirus Type 5-Based Oncolytic Viruses, Adenovirus Type 2-Based Oncolytic Viruses, Other Virus Types
2) By Application: Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Other Applications
3) By End-User: Hospitals, Cancer Research Institutes, Biotechnology Companies, Academic And Research Institutes

Subsegments:
1) By Adenovirus Type 5-Based Oncolytic Viruses: First-generation Adenovirus Type 5-based, Second-generation Adenovirus Type 5-based, Engineered Adenovirus Type 5-based
2) By Adenovirus Type 2-Based Oncolytic Viruses: First-generation Adenovirus Type 2-based, Second-generation Adenovirus Type 2-based, Engineered Adenovirus Type 2-based
3) By Other Virus Types: Modified Adenovirus Strains, Hybrid Adenovirus Types, Chimeric Adenoviruses

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21235&type=smp

What Long-Term Drivers Are Shaping Oncolytic Adenovirus Market Trends?
The growth of the oncolytic adenovirus market is anticipated to be driven by the escalating rates of cancer. Cancer, marked by uncontrolled cell multiplication and dissemination to other parts of the body, is primarily incited by aging demographics, lifestyle habits, environmental hazards, genetic predilections, and advancements in diagnostics. The special property of oncolytic adenovirus to selectively destruct cancer cells presents an encouraging strategy for tackling the surge in cancer incidence. For example, National Cancer Institute (NCI), a US government body reported that in May 2024, nearly 20 million new cancer cases emerged with 9.7 million deaths globally, and it projected that by 2040, these figures will escalate to 29.9 million cases and 15.3 million deaths. In addition, the Australian Bureau of Statistics, an Australian government body, reported in 2023 that 1.8% of Australians were diagnosed with cancer, with men (2.1%) being more prone than women (1.6%), particularly those over the age of 75. Consequently, the rising incidence of cancer is fueling the expansion of the oncolytic adenovirus market.

Who Are the Top Competitors in Key Oncolytic Adenovirus Market Segments?
Major companies operating in the oncolytic adenovirus market are Amgen Inc., Targovax ASA, CG Oncology Inc., Replimune Group Inc., Imugene Limited, Oncorus Inc., PsiOxus Therapeutics Ltd., Vyriad Inc., Transgene SA, Valo Therapeutics Oy, EpicentRx Inc., DNAtrix Inc., Shanghai Sunway Biotech Co. Ltd., TILT Biotherapeutics Ltd., Oncolys BioPharma Inc., Lokon Pharma AB, GeneMedicine Co. Ltd., Akamis Bio Ltd., Genelux Corporation, SillaJen Inc.

What Are the Major Trends Shaping the Oncolytic Adenovirus Market?
Leading organizations in the oncolytic adenovirus sector are concentrating on combined therapies like VCN-01. This therapy merges oncolytic virotherapy and chemotherapy for better targeting of tumors and boosting therapeutic results. VCN-01 is an engineered oncolytic adenovirus that is designed to selectively attack and eradicate cancer cells while also improving the potency of chemotherapy. For example, in May 2024, Theriva Biologics, an American clinical-phase immuno-oncology firm, reported that the U.S. Food and Drug Administration (FDA) endowed VCN-01 with the Fast Track Designation (FTD). This applies to VCN-01 when it is used alongside gemcitabine and nab-paclitaxel in treating metastatic pancreatic adenocarcinoma. VCN-01 being an oncolytic adenovirus, targets and multiplies within tumor cells thereby aiding in dissolving the tumor stroma, a crucial hurdle in effective cancer therapy.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/oncolytic-adenovirus-global-market-report

Which Regions Are Becoming Hubs for Oncolytic Adenovirus Market Innovation?
North America was the largest region in the oncolytic adenovirus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncolytic adenovirus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Oncolytic Adenovirus Market?
2. What is the CAGR expected in the Oncolytic Adenovirus Market?
3. What Are the Key Innovations Transforming the Oncolytic Adenovirus Industry?
4. Which Region Is Leading the Oncolytic Adenovirus Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.